A detailed history of Artemis Investment Management LLP transactions in Veracyte, Inc. stock. As of the latest transaction made, Artemis Investment Management LLP holds 10,050 shares of VCYT stock, worth $216,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,050
Previous 16,392 38.69%
Holding current value
$216,376
Previous $450,000 50.67%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$21.0 - $29.1 $133,182 - $184,552
-6,342 Reduced 38.69%
10,050 $222,000
Q4 2023

Jan 17, 2024

SELL
$19.72 - $28.68 $7,789 - $11,328
-395 Reduced 2.35%
16,392 $450,000
Q3 2023

Oct 16, 2023

BUY
$22.33 - $29.92 $101,288 - $135,717
4,536 Added 37.03%
16,787 $374,000
Q2 2023

Jul 19, 2023

SELL
$20.96 - $26.99 $25,738 - $33,143
-1,228 Reduced 9.11%
12,251 $312,000
Q1 2023

May 05, 2023

SELL
$20.58 - $27.89 $49,659 - $67,298
-2,413 Reduced 15.18%
13,479 $300,000
Q4 2022

Jan 25, 2023

SELL
$15.31 - $29.94 $47,445 - $92,784
-3,099 Reduced 16.32%
15,892 $0
Q3 2022

Oct 25, 2022

SELL
$16.58 - $27.9 $231,158 - $388,981
-13,942 Reduced 42.33%
18,991 $315,000
Q2 2022

Jul 22, 2022

SELL
$15.45 - $29.52 $157,868 - $301,635
-10,218 Reduced 23.68%
32,933 $656,000
Q1 2022

Apr 21, 2022

BUY
$21.94 - $42.51 $91,467 - $177,224
4,169 Added 10.69%
43,151 $1.19 Million
Q4 2021

Feb 08, 2022

BUY
$36.09 - $53.79 $250,248 - $372,979
6,934 Added 21.64%
38,982 $1.61 Million
Q3 2021

Oct 26, 2021

BUY
$35.62 - $52.97 $278,227 - $413,748
7,811 Added 32.23%
32,048 $1.49 Million
Q2 2021

Aug 04, 2021

BUY
$32.94 - $56.62 $798,366 - $1.37 Million
24,237 New
24,237 $970,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.54B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.